|
|||||
|
|
||||||
Journal of Clinical Oncology, Vol 26, No 14 (May 10), 2008: pp. 2272-2277 © 2008 American Society of Clinical Oncology. DOI: 10.1200/JCO.2007.14.7710 Tailored Chemotherapy Information Faxed to General Practitioners Improves Confidence in Managing Adverse Effects and Satisfaction With Shared Care: Results From a Randomized Controlled Trial
From the Supportive Care Research Group, Peter MacCallum Cancer Centre; Division of Surgical Oncology, Peter MacCallum Cancer Centre; Pharmacy, Peter MacCallum Cancer Centre; Faculty of Medicine, Dentistry and Health Sciences, University of Melbourne, Melbourne, Australia Corresponding author: Michael Jefford, MBBS, MPH, MHlthServMt, PhD, FRACP, Division of Haematology and Medical Oncology, Peter MacCallum Cancer Centre, Locked Bag 1, ABeckett St, Victoria 8006, Australia; e-mail: Michael.Jefford{at}petermac.org
Purpose General practitioners (GPs) play a critical role in the treatment of patients with cancer; yet often lack information for optimal care. We developed standardized information for GPs about chemotherapy (CT). In a randomized controlled trial we assessed the impact of sending, by fax, information tailored to the particular patient's CT regimen. Primary end points were: confidence treating patients who were receiving CT (confidence), knowledge of adverse effects and reasons to refer the patient to the treatment center (knowledge), and satisfaction with information and shared care of patients (satisfaction). Methods Focus group work informed the development of the CT information which focused on potential adverse effects and recommended management strategies. GPs of patients due to commence CT were randomly assigned to receive usual correspondence with or without the faxed patient/regimen-specific information. Telephone questionnaire at baseline and 1 week postintervention assessed knowledge, confidence, and satisfaction. Results Ninety-seven GPs managed 97 patients receiving 23 types of CT. Eighty-one (83.5%) completed the follow-up questionnaire. GPs in the intervention group demonstrated a significantly greater increase in confidence (mean difference, 0.28; 95% CI, 0.10 to 0.47) and satisfaction (mean difference, 0.57; 95% CI, 0.27 to 0.88) compared with usual care, reflecting a 7.1% and 10.5% difference in score, respectively. No differences were detected for knowledge. GPs receiving the CT sheet found correspondence significantly more useful (P < .001) and instructive (P < .001) than GPs who received standard correspondence alone. Conclusion Information about CT faxed to GPs is a simple, inexpensive intervention that increases confidence managing CT adverse effects and satisfaction with shared care. This intervention could have widespread application.
Many patients with cancer receive treatment as outpatients. This is becoming increasingly common, in part due to improved supportive measures and also due to pressure on inpatient resources. A push toward greater care in the community places increased demand on primary care doctors (general practitioners [GPs] referred to as family physicians in some countries). Many patients have long-established relationships with their GP and may consult them for advice regarding current cancer treatments.1,2 It is therefore vital that GPs have adequate knowledge of cancer treatments and feel confident managing these aspects of their patients care. Good communication is vital to ensure effective shared care between cancer treatment centers and community doctors.3 Unfortunately, many studies suggest that information provided to GPs is grossly inadequate.4-12 The literature suggests that GPs wish to receive information about proposed treatments, potential adverse effects, and how to manage these effects; however, frequently do not receive this information.5,6,10,12 McConnell et al10 found that 93.4% of GPs wanted information about adverse effects of treatments, 91.5% wished to receive suggestions for management of adverse effects, and 85.8% would like to be informed of indicators for unscheduled review by the oncologist. Actual letters contained this information in 16.2%, 5.1%, and 8.1% of cases. Pringle13 has suggested the reply letter is the "most neglected route of GP education."GPs are receptive to the use of referral replies as sources of learning.14 Gagliardi et al14 also note that GPs prefer continuing medical education that is directly related to their clinical work. GPs appear to have a preference for structured information, relevant to their needs.15,16 McConnell et al concluded "for GPs, standard information sheets may be included with the reply letter concerning the cancer type, potential side effects of the treatment proposed and recommendations for their management. More than 90% of GPs want this information and less than 20% of oncologist reply letters currently provide any of these details."10 Because of the strong desire for this information and the important role of GPs, at least in some countries, in the community management of people with cancer,1,2 we developed information materials for GPs regarding chemotherapy (CT), potential adverse effects, and their recommended management. The information was tailored to the specific type of CT the patient was receiving. The aim of this study was to examine the effectiveness of this information in improving GPs knowledge and confidence regarding the treatment of patients who were receiving CT, and their satisfaction with information provision and the perception of the shared care of the patients.
Hypotheses
Ethics Approval/Study Registration The Human Research Ethics Committee at Peter MacCallum Cancer Centre approved the study. It was registered with the Australian Clinical Trials Registry (number 12606000215527).
Phase 1: Development of Information Sheets
Phase 2: The Trial
Design and Procedure
Measures Unprompted recall of knowledge. GPs were asked "can you name possible side effects associated with your patient's CT regimen?" and "under what circumstances would you refer a patient receiving this CT regimen back to Peter Mac for management?" A medical oncologist, blinded to the participant's experimental group, rated responses as correct or incorrect. Correct responses were summed for the two items.
Satisfaction with communication.
GPs were asked to rate on a 5-point scale, from very dissatisfied to very satisfied how satisfied they were with the shared care of their patient between themselves and the treatment center and how satisfied they were with the communication they had received from the treatment center about their patient. Although not formally defined in Australia, shared care refers to collaboration between specialists/specialist centers and local health care practitioners. The two items were collapsed into a mean score. Internal consistency was
Perceptions of correspondence.
GPs were asked at follow-up how useful total received correspondence was. The eight items are listed in Figure 1 and were averaged into a single score. The internal consistency of this measure was
Statistical Analysis An intention-to-treat analysis was performed. Participants who withdrew from the study, reported not receiving information, or did not read the information, had their last observation carried forward for any analysis that compared baseline and follow-up scores. Relationships between personal and professional characteristics of GPs were explored for each outcome variable by Pearson's correlations and compared between treatment groups by 2 tests. Independent samples t tests were performed to test for differences between treatment groups at baseline. Comparisons of follow-up scores were tested by an analysis of covariance with baseline added as a covariate. All reported means, SEs, and 95% CIs for the major outcome variables were adjusted for the effect of baseline as a covariate. Significance level was set at = .05. Effect sizes were calculated using Hedge's g.
Focus Group General views regarding communication from treatment centers suggested that information was often received too late and often inadequate. Information frequently did not describe the proposed treatment, potential adverse effects, details of follow-up, or what was required of the GP. There was broad agreement that it was important to know about treatment intent, names of drugs, potential adverse effects, how to manage these, and when to refer back to the cancer center. It was suggested that, particularly for newer treatments, Internet references might be useful. Regarding the suggested cover sheet, it was important to know details of the treating doctor, type of cancer, and patient understanding of treatment intent. With respect to CT information, GPs strongly endorsed the single-page format. The preference was that information be sent directly to the patient's electronic medical record, but felt information sent by fax would be acceptable.
Cover Letter
Chemotherapy Sheets
Trial Profile
Twenty GPs (25%) reported that they did not receive any information. Of these, 17 were from the control group and three were from the intervention group. Further, five GPs (8%) reported not reading the information they did receive, three from the intervention, and two from the control group.
Sample Characteristics and Success of Randomization and Effects of the Intervention
Confidence and Knowledge At follow-up, GPs assigned to the intervention reported significantly greater levels of confidence in treating patients with CT adverse effects than GPs receiving usual correspondence (mean difference, 0.28; 95% CI, 0.10 to 0.47). This represented a 7.1% difference in score between groups. A medium effect size was observed (Hedge's g = 0.63). No differences were detected between groups for either knowledge of adverse effects (mean difference, 0.28; 95% CI, –0.33 to 0.88) or awareness of reasons to refer a patient back to the treatment center (mean difference, 0.19; 95% CI, –0.19 to 0.57).
Satisfaction
Perceptions of Correspondence/the Intervention GPs in the intervention were more likely to agree or strongly agree that information was instructive (96.7% v usual correspondence 42.3%; P < .001), easy to understand (92.9 v 73.1%; P < .005) and the right length (89.3% v 65.4%; P < .001; Fig 3).
Given the important role of GPs in the shared care of people affected by cancer and the known problems with communication between cancer treatment centers and community doctors, we sought to develop information for GPs that they perceived to be useful for their practice. Consistent with the literature,3,8 focus group results indicated that GPs wanted information about their patient's CT regimen, potential adverse effects, how to manage these, and when to refer back. Therefore, we developed information sheets for GPs about common CT regimens and evaluated their effectiveness in a randomized controlled trial. We found that providing GPs with standardized information relevant to their particular patient, in addition to usual correspondence, improved GPs confidence managing CT adverse effects and their level of satisfaction with the shared care of their patient and with communication received from the treatment center. Compared with GPs receiving usual correspondence alone, those who also received the faxed information were more likely to consider correspondence to be useful, instructive, and easy to understand. However, the study did not result in increased GP knowledge of CT adverse effects. This may be due to measurement issues. There was variation in the level of detail and precision of GPs unprompted recall of adverse effects and reasons to refer the patient back (eg, febrile neutropenia or progressive cardiomyopathy as potential adverse effects versus generally unwell or malaise). Despite this, responses were all awarded the same score per correct response. Measuring knowledge based on a sum of correct responses may have failed to distinguish responses that were more meaningful than others. That is to say, a response such as "a possible side effect of CT x is febrile neutropenia" might be considered to reflect a greater understanding than "malaise". It might also be that GPs did not necessarily study the CT sheet; rather, using it as a reference if the patient needed assistance. Awareness that useful information was at hand may have mediated GPs confidence in treating patients receiving CT. A further limitation is that the outcome measures do not have proven reliability and validity. An encouraging observation was that GPs, despite being extremely busy, were keen to participate in the study, as demonstrated by a high response rate. Our belief, borne out by comments from some participants, was that this was because the intervention was timely, useful, relevant to their patient's care, and clinically relevant. We are encouraged to use this strategy in other research studies; for example, in providing GPs with information about survivorship care after completion of cancer treatments, as recommended by the Institute of Medicine report, From Cancer Patient to Cancer Survivor: Lost in Transition.17 Others have investigated the effect of providing GPs with additional information about cancer and cancer treatments. James et al18 reported that GPs found that a general information pack about pediatric oncology helped them to care for pediatric patients with cancer and their families. The authors also reported the pack improved communications between GPs and the oncology department. A study from Denmark assessed the impact of a structured oncology information pack sent to GPs when newly referred patients visited the oncology department for the first time.19 The pack appeared to improve GP knowledge and GPs felt more confident supporting their patients. Furthermore, GPs satisfaction with the oncology department improved. This reflects our findings in terms of satisfaction and confidence, but not knowledge. Notably, however, this study assessed improved knowledge in the intervention group only, and used a single self-report item "did you feel that the information material had improved your knowledge of oncology and intersectional cooperation?" There are indications that these types of intervention not only improve the perceptions of GPs but also patients. A shared care program between an oncology department in Denmark and GPs included transfer of information between doctors and improved communication processes.20 The program had a positive effect on patients perceptions of cooperation between the hospital and community settings. Patients perceptions of their GPs knowledge appeared higher for GPs assigned to the intervention group. The rationale for this study was that the intervention might have a number of potential benefits. Patients may experience improved care as a result of more integrated health care delivery. They might also experience fewer uncontrolled adverse effects as a result of their GP's improved confidence. For GPs, improved information might improve knowledge, confidence, and satisfaction with shared care with the treatment center. For the treatment center, the intervention may lead to fewer unplanned admissions due to inadequately controlled adverse effects, potentially fewer admissions of seriously unwell patients, more rapid triage of patients with life-threatening adverse effects, such as febrile neutropenia, and hopefully also an improved relationship with the GP community. Many of the above benefits remain untested; however, we are encouraged by the positive impact on GPs and the work by Nielsen et al.20 In this study, standard information about CT treatments, potential adverse effects, how to manage these adverse effects, and when to contact the treatment center was developed for GPs. GPs found the information useful and instructive. When evaluated in a randomized, controlled trial, GPs who received this information in addition to usual correspondence, were more confident treating patients who were receiving CT and were more satisfied with the shared care of their patient and with communication received from the hospital. This is an effective, rapid, and inexpensive intervention that should be widely implemented and has the potential to improve outcomes for patients, as well as for GPs and cancer treatment centers.
The author(s) indicated no potential conflicts of interest.
Conception and design: Michael Jefford, Adrian Dabscheck, Penelope Schofield Administrative support: Michael Jefford, Carl Baravelli, Adrian Dabscheck, Melanie Evans, Michael Moloney, Penelope Schofield Provision of study materials or patients: Michael Jefford, Carl Baravelli, Melanie Evans, Michael Moloney, Penelope Schofield Collection and assembly of data: Michael Jefford, Carl Baravelli, Melanie Evans, Penelope Schofield Data analysis and interpretation: Michael Jefford, Carl Baravelli, Paul Dudgeon, Penelope Schofield Manuscript writing: Michael Jefford, Carl Baravelli, Penelope Schofield Final approval of manuscript: Michael Jefford, Carl Baravelli, Paul Dudgeon, Adrian Dabscheck, Melanie Evans, Michael Moloney, Penelope Schofield
We thank Richard Fisher, PhD, for reviewing the manuscript and all GP participants.
Supported by unrestricted educational grant from Roche Products (Australia). Presented in part at the 43rd Annual Meeting of the American Society of Clinical Oncology, June 1-5, 2007, Chicago, IL. Authors disclosures of potential conflicts of interest and author contributions are found at the end of this article.
1. Kendall M, Boyd K, Campbell C, et al: How do people with cancer wish to be cared for in primary care? Serial discussion groups of patients and careers. Fam Pract 23:644-650, 2006 2. Williams PT: The role of family physicians in the management of cancer patients. J Cancer Educ 9:67-72, 1994[Medline] 3. Hampson JP, Roberts RI, Morgan DA: Shared care: A review of the literature. Fam Pract 13:264-279, 1996 4. Westerman RF, Hull FM, Bezemer PD, et al: A study of communication between general practitioners and specialists. Br J Gen Pract 40:445-449, 1990[Medline] 5. Tattersall MH, Griffin A, Dunn SM, et al: Writing to referring doctors after a new patient consultation: What is wanted and what was contained in letters from one medical oncologist? Aust N Z J Med 25:479-482, 1995[Medline] 6. Tattersall MH, Butow PN, Brown JE, et al: Improving doctors letters. Med J Aust 177:516-520, 2002[Medline] 7. Stalhammar J, Holmberg L, Svardsudd K, et al: Written communication from specialists to general practitioners in cancer care: What are the expectations and how are they met? Scand J Prim Health Care 16:154-159, 1998[CrossRef][Medline] 8. Newton J, Hutchinson A, Hayes V, et al: Do clinicians tell each other enough? An analysis of referral communications in two specialties. Fam Pract 11:15-20, 1994 9. Newton J, Eccles M, Hutchinson A: Communication between general practitioners and consultants: What should their letters contain? BMJ 304:821-824, 1992 10. McConnell D, Butow PN, Tattersall MH: Improving the letters we write: An exploration of doctor-doctor communication in cancer care. Br J Cancer 80:427-437, 1999[CrossRef][Medline] 11. Johansson B, Berglund G, Hoffman K, et al: The role of the general practitioner in cancer care and the effect of an extended information routine. Scand J Prim Health Care 18:143-148, 2000[CrossRef][Medline] 12. Babington S, Wynne C, Atkinson CH, et al: Oncology service correspondence: Do we communicate? Australas Radiol 47:50-54, 2003[CrossRef][Medline] 13. Pringle M: Referral letters: Ensuring quality. Practitioner 235:507-510, 1991[Medline] 14. Gagliardi A: Use of referral reply letters for continuing medical education: A review. J Contin Educ Health Prof 22:222-229, 2002[CrossRef][Medline] 15. Ray S, Archbold RA, Preston S, et al: Computer-generated correspondence for patients attending an open-access chest pain clinic. J R Coll Physicians Lond 32:420-421, 1998[Medline] 16. Dunn DC, Dale RF: Combined computer generated discharge documents and surgical audit. BMJ (Clin Res Ed) 292:816-818, 1986 17. Institute of Medicine: From Cancer Patient to Cancer Survivor: Lost in Transition. Washington, DC, National Academies Press, 2005 18. James JA, Harris DJ, Mott MG, et al: Paediatric oncology information pack for general practitioners. BMJ (Clin Res Ed) 296:97-98, 1988 19. Kousgaard KR, Nielsen JD, Olesen F, et al: General practitioner assessment of structured oncological information accompanying newly referred cancer patients. Scand J Prim Health Care 21:110-114, 2003[CrossRef][Medline] 20. Nielsen JD, Palshof T, Mainz J, et al: Randomised controlled trial of a shared care programme for newly referred cancer patients: Bridging the gap between general practice and hospital. Qual Saf Health Care 12:263-272, 2003 Submitted October 4, 2007; accepted December 12, 2007.
Related Editorial
This article has been cited by other articles:
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|||||||||||
|
Copyright © 2008 by the American Society of Clinical Oncology, Online ISSN: 1527-7755. Print ISSN: 0732-183X
|